Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$47.4K Buy
967
+6
+0.6% +$279 ﹤0.01% 555
2025
Q4
$41.9K Buy
961
+720
+299% +$32.9K ﹤0.01% 378
2025
Q3
$10.8K Hold
241
﹤0.01% 613
2025
Q2
$10.5K Hold
241
﹤0.01% 591
2025
Q1
$11.1K Hold
241
﹤0.01% 591
2024
Q4
$9.07K Hold
241
﹤0.01% 635
2024
Q3
$9.77K Hold
241
﹤0.01% 628
2024
Q2
$8.34K Hold
241
﹤0.01% 634
2024
Q1
$9.05K Hold
241
﹤0.01% 620
2023
Q4
$8.65K Hold
241
﹤0.01% 589
2023
Q3
$9.11K Hold
241
﹤0.01% 561
2023
Q2
$9.82K Hold
241
﹤0.01% 568
2023
Q1
$10.1K Hold
241
﹤0.01% 550
2022
Q4
$10.4K Hold
241
﹤0.01% 524
2022
Q3
$9K Hold
241
﹤0.01% 548
2022
Q2
$11K Hold
241
﹤0.01% 497
2022
Q1
$11K Buy
+241
New +$10.2K ﹤0.01% 512
2020
Q1
Sell
-983
Closed -$32K 675
2019
Q4
$32K Buy
+983
New +$31.8K 0.02% 179
2018
Q2
Sell
-203
Closed -$6K 528
2018
Q1
$6K Hold
203
﹤0.01% 319
2017
Q4
$6K Buy
+203
New +$5.83K ﹤0.01% 338

Other funds holding EXC

McIlrath & Eck's EXC Position: Q1 2026 in Review

McIlrath & Eck increased its Exelon (EXC) stake by 0.62% in Q1 2026, buying an estimated $279 and bringing the position to 967 shares worth $47.4K. The position accounts for ﹤0.01% of the portfolio, ranked #555.

McIlrath & Eck first reported a position in EXC in Q4 2017 and has held it in 20 quarters since. 1,277 funds tracked by Wall St. Rank hold EXC as of Q1 2026.

  • McIlrath & Eck held 967 shares of Exelon worth $47.4K as of Q1 2026.
  • McIlrath & Eck bought 6 Exelon shares in Q1 2026, an estimated $279.
  • Exelon made up ﹤0.01% of McIlrath & Eck's portfolio in Q1 2026, its #555 holding.
  • McIlrath & Eck first reported a position in Exelon in Q4 2017 and has held it in 20 quarters since.
  • 1,277 funds tracked by Wall St. Rank held Exelon as of Q1 2026.

Based on McIlrath & Eck's 13F filing for Q1 2026, filed 19 May 2026.